Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Cataract
Share your love
SERI and ZEISS Partner to Improve Vision Care
The Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec have launched a groundbreaking collaboration aimed at advancing cataract and refractive surgery outcomes. The initiative, called Ophthalmic Tech Innovation by ZEISS and SERI (OPTIZS), involves a combined investment of nearly…
Alcon’s IOL Faces Probe by CDSCO
The Central Drugs Standard Control Organisation (CDSCO) has formed a committee to investigate allegations of quality issues with an intraocular lens (IOL) supplied by Alcon. The Swiss-American company specializes in eye care products, including lenses for cataract surgery. Specifics of…
OBN Spotlight TV: Interview with Hillary A. Golden
In late October, Medicare introduced proposed Local Coverage Determinations (LCDs) that aimed to impose restrictions on Minimally Invasive Glaucoma Surgery (MIGS) procedures. These LCDs were met with significant concern and opposition from medical professionals, patient advocacy groups, and the ophthalmology…
Top 15 International Ophthalmology Congresses in 2024
As the field of ophthalmology continues to advance, a plethora of international congresses offer opportunities for professionals to explore the latest innovations, share insights, and foster collaborations. Here is a comprehensive list of the top 15 international ophthalmology conferences scheduled…
Tarsus Appoints Dr. Elizabeth Yeu as Chief Medical Officer
Tarsus Pharmaceuticals has announced the appointment of Elizabeth Yeu, MD, as Chief Medical Officer, effective November 4, 2024. Dr. Yeu, an esteemed ophthalmologist with over two decades of clinical and leadership experience, will lead the company’s medical organization and oversee…
Formosa: Positive Phase 3 Results for APP13007 in China
Formosa Pharmaceuticals recently announced the completion of CPN-303, a Phase 3 clinical trial conducted in Chinese cataract surgery patients to evaluate APP13007 (GPN00833). This trial, managed by Formosa’s licensee Grand Pharma (0512.HK), demonstrated positive top-line results, showcasing APP13007’s effectiveness in…
VSY Biotechnology Unveils Maestro® Sinusoidal IOL at ESCRS24
VSY Biotechnology to Complete Global Rollout of its Sinusoidal Vision Technology (SVT®) at ESCRS 2024 This year’s European Society of Cataract and Refractive Surgeons (ESCRS) 2024 kicked off with the highly anticipated third iNovation Day, which brought together the medical…
How Smoking Affects Your Eye Health
Smoking is widely recognized as a major health hazard, contributing to a range of systemic diseases, including lung cancer, heart disease, and stroke. However, the harmful effects of smoking extend beyond these well-known conditions, significantly impacting eye health as well.…
What Is Suprachoroidal Hemorrhage? | OBN
What Is Suprachoroidal Hemorrhage? Suprachoroidal hemorrhage is a sight-destroying pathology. It arises when there is a rupture of long or short ciliary arteries during an intraocular surgery and blood is contained in the space between the choroid and the sclera.…
Peters Anomaly: Causes, Symptoms and Management
What Is Peters Anomaly? Peters anomaly is a rare congenital ocular condition primarily affecting the anterior segment of the eye. At its core, it’s characterized by the abnormal development of the cornea’s central layers and potential adhesions between the cornea…